Atticus Wealth Management, LLC Bio N Tech Se Transaction History
Atticus Wealth Management, LLC
- $285 Million
- Q3 2024
A detailed history of Atticus Wealth Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Atticus Wealth Management, LLC holds 2 shares of BNTX stock, worth $253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$253
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.05 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$573 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$553 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$240 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$229 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $30.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...